At Geliad, we are dedicated to exploring and developing next-generation APIs that cater to the evolving demands of the pharmaceutical industry. Our R&D team works closely with scientists and industrial partners to:
✅ Develop innovative and high-purity APIs.
✅ Optimize synthesis processes for efficiency and cost-effectiveness.
✅ Ensure strict compliance with global regulatory standards (ICH, US FDA, EMA, NMPA).

Our focus includes small-molecule APIs, high-potency APIs (HPAPIs), oncology compounds, cardiovascular drugs, and specialty APIs.

Navigating pharmaceutical regulations is a complex process. At Geliad, we help our partners with:
✔ CTD dossiers, DMFs, and regulatory filings.
✔ Regulatory intelligence on China’s evolving API policies.
✔ Support for GMP audits and quality certifications.

Our team ensures that all regulatory documentation is in place, streamlining approvals in Europe, the US, Southeast Asia, the Middle East, and Latin America.

At Geliad, we are constantly investing in:
🔬 New molecule development in high-demand therapeutic segments.
🌍 Expanding our global footprint through strategic partnerships.
⚡ Advanced technologies in API manufacturing for sustainable production.

We aim to lead the pharmaceutical industry by delivering innovative, high-quality, and cost-effective solutions that contribute to better healthcare worldwide.

Shanghai Geliad Biotechnology Co. Ltd. is a dynamic and innovation-driven pharmaceutical company based in China. We specialize in the research, development, sourcing, and export of small-scale, novel, and advanced Active Pharmaceutical Ingredients (APIs). Our mission is to bridge the gap between cutting-edge pharmaceutical innovations in China and global pharmaceutical markets.

With a commitment to excellence, regulatory compliance, and market-driven solutions, we collaborate with pharmaceutical manufacturers, research institutions, and healthcare companies worldwide.